MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$7,397K
EPS
$0.63
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
-
0
5,150*
-
Clinical expense
-
2,015
-
-
Preclinical expense
-
247
-
-
Chemistry, manufacturing, and controls
-
555
-
-
Total revenue
235
-
-
334
Ipr&d expense
-
8,000
-
-
Research and development
3,891
-
-9,227*
5,452
Selling, general and administrative
4,119
4,588
3,876*
3,287
Total operating expenses
8,010
-
-5,352*
8,739
Gain from operations
-7,775
-
10,502
-8,405
Amortization of debt issuance costs and discount
0
-
0
0
Interest income
685
535
437
454
Interest expense
0
0
0
0
Other income
335
-
0*
-
Warrant liabilities fair value adjustment
-14,152
-
-1,319
640
Derivative liability fair value adjustment
-
-
0*
0
Total other income
15,172
-
1,756
-186
Gain before taxes
-
-
12,258
-8,591
Other segment expense (income)
-
-6,429
-
-
Segment net loss
-
-21,299
-
-
Income tax expense
-
-
0
0
Adjustments and reconciling items
-
0
-
-
Net income (gain)
7,397
-21,299
12,258
-8,591
Basic EPS
0.63
-0.42
0.242
-0.17
Diluted EPS
0.63
-0.42
0.242
-0.17
Basic Average Shares
11,824,078
50,957,191
50,650,213
49,898,892
Diluted Average Shares
11,824,078
50,957,191
50,650,213
49,898,892
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Warrant liabilities
fair value...
-$14,152K
(-553.37%↓ Y/Y)
Interest income
$685K
(34.31%↑ Y/Y)
Other income
$335K
Total other income
$15,172K
(466.97%↑ Y/Y)
Net income (gain)
$7,397K
(207.44%↑ Y/Y)
Gain from operations
-$7,775K
(18.68%↑ Y/Y)
Total revenue
$235K
(-82.77%↓ Y/Y)
Total operating
expenses
$8,010K
Selling, general and
administrative
$4,119K
Research and development
$3,891K
Buy us a coffee
SCYNEXIS INC (SCYX)
SCYNEXIS INC (SCYX)